Open- Label Trial of Sipuleucel-T Administered to Active Surveillance Patients for Newly Diagnosed Prostate Cancer

NCT03686683 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

532

Enrollment

INDUSTRY

Sponsor class

Conditions

Adenocarcinoma of the Prostate

Interventions

BIOLOGICAL: sipuleucel-T

Sponsor

Dendreon

Collaborators

[object Object]